HIIFS
AVNS

Harel Insurance Investments & Financial Services’s Avanos Medical AVNS Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,347
Closed -$237K – 656
2023
Q2 		$237K Buy
+9,347
New +$246K 0.01% 295
2016
Q2 		– Sell
-8
Closed – – 687
2016
Q1 		$0 Buy
+8
New +$213 ﹤0.01% 443

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harel Insurance Investments & Financial Services's AVNS Position: Q3 2023 in Review

Harel Insurance Investments & Financial Services sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 9,347 shares — an estimated $237K sold.

Harel Insurance Investments & Financial Services first reported a position in AVNS in Q1 2016 and held it in 2 quarters. The position peaked at $237K in Q2 2023. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Harel Insurance Investments & Financial Services reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 9,347 Avanos Medical shares in Q3 2023, an estimated $237K.
  • Harel Insurance Investments & Financial Services first reported a position in Avanos Medical in Q1 2016 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's Avanos Medical position peaked at $237K in Q2 2023.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2023, filed 30 Oct 2023.